medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2019, Number 2

<< Back Next >>

Cir Card Mex 2019; 4 (2)

Heart-lung transplant: Pedes in terra ad sidera visus. Case report and review of the literature

Orozco-Hernandez EJ, Argueta-Sosa E, Hoopes CW

Language: English
References: 14
Page: 54-64
PDF size: 857.18 Kb.


ABSTRACT

Heart-lung block transplant is currently a modality for some patients with advanced and refractory cardiopulmonary disease.The survival rate is 70% at one year. Causes for early postoperative mortality, are graft failure and hemorrhage. Late complications are complex, from cardiac allograft vasculopathy to bronchiolitis obliterans, and malignancy, with skin cancer being the most frequent. Currently 80-90% of the patients receive some type of pharmacologic therapy for induction, the typical regimen for immunosuppression maintenance is tacrolimus and mycophenolate. We present a case of severe pulmonary hypertension and ASD , treated successfully with a heart-lung block transplant.


REFERENCES

  1. Reitz BA. Heart-Lung Transplantation. Chest 1988;93:450-1

  2. Chambers DC, Cherikh WS, Goldfarb S, et al. The Registry of the InternationalSociety for Heart and Lung Transplantation: thirty-fifth adult heart transplantationreport 2018; focus theme: multiorgan transplantation. J Heart Lung Transplant2018;37:1169-83.

  3. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinaryclassification of the idiopathic interstitial pneumonias. Am J Respir CritCare Med 2013;188:733-48.

  4. Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the InternationalSociety for Heart and Lung Transplantation: thirtyfourth adult lung and heart-lungtransplantation report2017; focus theme: allograft ischemic time. J Heart LungTransplant. 2017 Oct;36(10):1047-59.

  5. Cavarocchi NC, Badellino M. Heart/Heart-Lung Transplantation. The DominoProcedure. Ann Thor Surg 1989;48:130-3.

  6. Griffith BP, Magliato KE. Heart and Lung Transplantation. Oper Tech Thorac CardiovascSurg 1999;4:124-41.

  7. Rose J, Zimmerman H, Coelho-Anderson R, Copeland JG. Twenty-five-yearsurvival after heart-lung transplantation: A milestone. J Heart Lung Transplant2011;30:385-8.

  8. Patterson GA, Cooper JD, Dark JH et al. Experimental and clinical double lungtransplantation. J Thorac Cardiovas Surg 1988;95:70-4.

  9. Vouche PR, Dartevelle PG. Heart-Lung Transplantation.Technical modificationsthat may improve the early outcome. J Thorac Cardiovasc Surg 1989;97:906-10.

  10. Haverich A, Frimpong-Boateng K, Whalers T, et al. Pericardial-flap plasty forprotection of the tracheal anastomosis in Heart-Lung transplantation. J Card Surg1989;4: 136-9.

  11. Emery RW, Arom KV, Von Rueden T, Copeland JG. Use of the pericardial fat padin pulmonary transplantation. J Card Surg 1990;5:145-8.

  12. Pelletier MP, Coady M, Ahmed S, Lamb J, Reitz BA, Robbins RC. Successful Repairof tracheal dehiscence after heart–lung transplantation. J Heart Lung Transplant2005;24:99-101.

  13. Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Societyfor Heart and Lung Transplantation: twenty-sixth official adult lung and heart-lungtransplantation report—2009. J Heart Lung Transplant 2009;28:1031-49.

  14. McCarthy PM, Starnes VA, Theodore J, Stinson EB, Oyer PE, Shumway NE.Improved survival after heart-lung transplantation. J Thorac Cardiovasc Surg1990;99:54-9.




2020     |     www.medigraphic.com